# Pharmacogenomic Evaluation of Antihypertensive Responses 2

> **NCT01203852** · PHASE4 · COMPLETED · sponsor: **University of Florida** · enrollment: 839 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Metoprolol
- **DRUG:** Chlorthalidone

## Key facts

- **NCT ID:** NCT01203852
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 839 (ACTUAL)
- **Last updated:** 2018-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01203852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01203852, "Pharmacogenomic Evaluation of Antihypertensive Responses 2". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01203852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*